Imaging Scans to Guide Heart Pacing Device Placement in Heart Failure
Tests whether heart scans guide device placement in adults with weakened-heart failure.
Plain-language title generated from the registry record
Registry title: Mechanistic Clinical Trial of Advanced Imaging for CRT
Key facts
- Where
- Charlottesville, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 90 years old?
Source: NCT03398369, who can take part
Where in United States
- University of Virginia Health SystemCharlottesville, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Virginia
- Trial code
- NCT03398369
- Record updated
- 6 February 2020
- Original description
This is a mechanistic clinical trial with randomization to guidance for the CRT procedure using cardiac magnetic resonance (CMR) and computed tomography angiography (CTA) versus a standard procedure.Read full original descriptionShow less
Advanced Imaging and Inflammatory Markers to Define Mechanisms of Response to CRT
This is a mechanistic clinical trial with randomization to guidance for the CRT procedure using cardiac magnetic resonance (CMR) and computed tomography angiography (CTA) versus a standard procedure.
Inclusion: Chronic systolic HF; LVEF 35% or less; Guideline-based class I or II indication for CRT.
Exclusion: Presence of metal embedded in the body due to prior accident or injury, as documented by skull films or other imaging; Cochlear implants; Other metallic implants known to be contraindications to CMR (does not include pacemakers and ICDs); Liver transplant; Gadolinium allergy; Acute renal failure or chronic kidney disease with GFR < 45 cc/min/1.73m2; Inability to provide informed consent; Pregnancy; Cerebral aneurysm clips; Severe claustrophobia; Acute kidney injury; >10% premature ventricular contraction (PVC) burden; and 13) estimated >10% atrial fibrillation (AF) burden based on available clinical data.